General practitioners knowledge of and attitudes to the use of seat belts in pregnancy

C Wallace1

  • 1Training Programme in General Practice, Mid-Western Health Board, Limerick.

Irish Medical Journal
|March 1, 1997
PubMed

This study was designed to look at General Practitioner's knowledge of and attitudes to the use of seat belts in pregnancy. It has been shown that correct seat belt use does significantly reduce both maternal and fetal morbidity and mortality following RTAs. However, seat belts are infrequently and often incorrectly utilised by women during pregnancy. Passenger safety education is essential. General Practitioners in Ireland are in a prime position to provide this education in early pregnancy. A postal questionnaire was sent to all members of ICGP (n = 1,780). The results show that 70% of GPs are aware that women are obliged by law to use a seat belt while pregnant, and a similar number felt the subject of passenger safety education is an important medical issue. 75% feel women should wear seat belts in third trimester. However, only 30% provide regular advice and less than 50% indicated that they are aware of the correct advice to give. Also GPs are not asked by their pregnant patients for advice. There is no statistically significant difference between male and female GPs. GPs have the opportunity to and so should provide passenger safety advice. This advice must be accurate and safe.

Related Concept Videos

PPE Use in Healthcare Settings I: Donning01:22

PPE Use in Healthcare Settings I: Donning

Donning PPE must be completed before contact with the patient. This process protects from infectious agents. The sequence and action included in each donning are critical, and the steps must be systematic to avoid exposure to pathogens. The institutional policy also needs to be followed while donning PPE. The pre-donning preparations are gathering equipment, inspecting the PPE equipment for tears, holes, or damage, removing jewelry, removing any garments below the elbows, and tying the hair...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...